NCT01607905 Safety Study of KPT-330 (Selinexor) in Patients With Advanced or Metastatic Solid Tumor Cancer Status COMPLETED Phase PHASE1
NCT01596140 Vemurafenib in Combination With Everolimus or Temsirolimus With Advanced Cancer Status COMPLETED Phase PHASE1
NCT01585623 Drug Interaction Study of SAR302503 in Patients With Solid Tumor Status COMPLETED Phase PHASE1
NCT01553071 Phase I Trial of IV Fenretinide (4-HPR) Plus IV Safingol for Patients With Relapsed Malignancies Status TERMINATED Phase PHASE1
NCT01540175 Immune Reconstitution in Oncology Patients Following Autologous Stem Cell Transplant Status COMPLETED Phase N/A
NCT01473095 Phase 1 Dose Escalation Study of ARQ 092 in Adult Subjects With Advanced Solid Tumors and Recurrent Malignant Lymphoma Status COMPLETED Phase PHASE1
NCT01463982 Phase I of OratecanTM in Combination With Capecitabine in Patients With Advanced Solid Malignancies Status COMPLETED Phase PHASE1
NCT01432951 A Study of Enzastaurin in Chinese Patients With Advanced and/or Metastatic Solid Tumors or Lymphoma Status COMPLETED Phase PHASE1
NCT01425008 Study of MLN2480 in Participants With Relapsed or Refractory Solid Tumors Followed by a Dose Expansion in Participants With Metastatic Melanoma Status COMPLETED Phase PHASE1
NCT01415258 Screening for Vulnerability in the Elderly Supported at the Oscar Lambret Centre Status COMPLETED Phase N/A
NCT01401504 Study of an Investigational Drug, ASP3026, in Patients With Solid Tumors Status COMPLETED Phase PHASE1
NCT01388335 A Drug Interaction Study to Assess the Effect of LY317615 on the Metabolic Pathway of Warfarin Status COMPLETED Phase PHASE1
NCT01383473 Concurrent School Attendance And Cancer Therapy: The Experiences of 6-12 Year Old Pediatric Oncology Patients Status COMPLETED Phase N/A
NCT01364844 Safety and Tolerability of DS-7423 in Subjects With Advanced Solid Malignant Tumors Status COMPLETED Phase PHASE1
NCT01363024 Trial Evaluating the Safety and Pharmacokinetics of MFGR1877S in Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT01359696 A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GDC-0425 Administered With and Without Gemcitabine in Patients With Refractory Solid Tumors or Lymphoma Status COMPLETED Phase PHASE1
NCT01337765 Safety, Pharmacokinetics and Pharmacodynamics of BEZ235 Plus MEK162 in Selected Advanced Solid Tumor Patients Status COMPLETED Phase PHASE1